Entity
Description
  • Value proposition

    Cell Therapy for All

    TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.

    TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.

    Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.

    Cell Therapy, Stem Cell, Stem cell mass-production, Cell therapy cGMP manufacturing, biomimetic 3D cell culture, and bioreactor stem cell cultivation

  • Original language

    Cell Therapy for All

    TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.

    TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.

    Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.

  • TreeFrog Therapeutics I iPS-derived Cell Therapies I Cell Therapy for All

    TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.

  • https://treefrog.fr/
Corporate interactions BETA
Corporate TypeTweets Articles
MassChallenge
MassChallenge
Startup accelerator & VC, Venture Capital and Private Equity Principals
MassChallenge
Startup accelerator & VC, Venture Capital and Private Equity Principals
Not capitalistic
Not partnership
Event

6 Nov 2019


AQUITI Gestion
AQUITI Gestion
Startup accelerator & VC, Venture Capital and Private Equity Principals
AQUITI Gestion
Startup accelerator & VC, Venture Capital and Private Equity Principals
Not capitalistic
Partnership
Event

3 Sep 2020

22 May 2024



Vertex Pharmaceuticals
Vertex Pharmaceuticals
Biotechnology, Biotechnology Research
Vertex Pharmaceuticals
Biotechnology, Biotechnology Research
Other

14 Jan 2021

20 Oct 2024



Up Grade Nouvelle-Aquitaine
Up Grade Nouvelle-Aquitaine
Civic and Social Organizations
Up Grade Nouvelle-Aquitaine
Civic and Social Organizations
Not capitalistic
Partnership
Event

15 May 2019


INVIVOLIM
INVIVOLIM
Biotechnology, Biotechnology Research
INVIVOLIM
Biotechnology, Biotechnology Research
Not capitalistic
Not partnership
Event

15 May 2019


Genopole
Genopole
Biotechnology, Biotechnology Research
Genopole
Biotechnology, Biotechnology Research
Not capitalistic
Partnership
Event

22 Mar 2021


Digital Aquitaine
Digital Aquitaine
IT Services and IT Consulting
Digital Aquitaine
IT Services and IT Consulting
Capitalistic
Not partnership
Not event

11 Jan 2019


PULSALYS
PULSALYS
Research, Research Services
PULSALYS
Research, Research Services
Not capitalistic
Not partnership
Event

1 Oct 2020


UNITEC
UNITEC
IT Services and IT Consulting
UNITEC
IT Services and IT Consulting
Not capitalistic
Partnership
Event

13 May 2021

28 Jun 2024



Similar entities
Loading...
Loading...
Social network dynamics